Sweden is an EU Member State. That means medical devices here fall under EU MDR (Regulation (EU) 2017/745) and IVDR (Regulation (EU) 2017/746), with Swedish supplementing law layered on top. CE marking may enable market access across the EU, but Sweden still requires national registration/notification with the MPA and clear economic operator obligations on top of that.
This article walks through Sweden’s registration process step by step. It starts with classification and ends with post-market surveillance.
Regulatory Authorities for Medical Devices in Sweden
The European Commission sets the EU-wide rules. Inside Sweden, the Medical Products Agency (MPA) handles registration and national compliance.
Medical Products Agency (MPA / Läkemedelsverket)
The MPA is a Swedish government agency, operating under the Ministry of Health and Social Affairs. Medical devices placed on the Swedish market fall under its remit. So do medicines and cosmetics, though device oversight is the focus here.
In the medical device space specifically, the MPA runs the national registration system for certain economic operators and devices, handles Swedish-language requirements and carries out market surveillance once devices are in circulation.
European Commission
The European Commission owns the EU MDR and IVDR texts. It also coordinates the Medical Device Coordination Group (MDCG), and the guidance MDCG issues gets used across every member state, Sweden included.
Other Relevant Regulatory Bodies and Systems
Eudamed: The EU’s central device database. As of 28 May 2026, registration in Eudamed became mandatory for medical device economic operators and their devices, per the MPA’s own published guidance.
Notified Bodies: They assess higher-risk devices for CE marking. Notified bodies designated in Sweden, along with those in other member states, are listed on the EU’s NANDO database.
Swedish Customs (Tullverket): It handles import and customs clearance procedures separately from regulatory conformity checks.
Sweden Medical Device Classification
Sweden does not run its own classification scheme. Medical Device Classification Sweden follows the same EU-wide, risk-based system used in every member state, set out in MDR Annex VIII.
| MDR Class | Risk Level | Conformity Route |
| Class I | Low |
Manufacturer self-declaration in most cases (Notified Body required only for sterile, measuring, or reusable surgical instrument features)
|
| Class IIa | Low–medium | Notified Body assessment |
| Class IIb | Medium–high | Notified Body assessment |
| Class III | Highest |
Notified Body assessment, generally with more extensive clinical evidence requirements
|
Classification affects far more than paperwork. It decides whether a Notified Body gets involved at all. It shapes how much clinical evidence is expected and how detailed the technical file needs to be. Post-market obligations follow the same logic once the device reaches the Swedish market.
Getting the class wrong early is expensive. Technical files built for the wrong class almost always need substantial rework later.
Authorized Representative (EC REP) Requirements in Sweden
A company based outside the EU that wants to sell into Sweden needs an EU Authorized Representative first. The device can’t reach the market without one. This comes from MDR Article 11, an EU-wide obligation, and it doesn’t matter whether Sweden is the first EU market a manufacturer enters or the fifth.
The Authorized Representative:
- Must be established within the EU (not necessarily in Sweden)
- Acts on a written mandate from the manufacturer, per MDR Article 11(3)
- Verifies the EU Declaration of Conformity and technical documentation are available
- Cooperates with the MPA and other national authorities on corrective actions
- Has its name and address indicated on the device label where the manufacturer does not have a registered place of business in the EU, as per MDR Annex I, Chapter III, Section 23.2(d)
MDR Article 15 also requires manufacturers and their Authorized Representatives to have a Person Responsible for Regulatory Compliance (PRRC).
Medical Device Regulatory Guidelines in Sweden
For anyone doing regulatory work on Swedish market entry, the source hierarchy runs roughly like this. EU MDR and IVDR first, European Commission and MDCG guidance second, Swedish national legislation and MPA guidance third and applicable harmonised standards and other recognised technical standards fourth.
- EU MDR (Regulation (EU) 2017/745) and IVDR (Regulation (EU) 2017/746)
- European Commission medical device guidance and MDCG position papers
- Swedish supplementing law: Lag (2021:600) and Förordning (2021:631)
- MPA regulations, including HSLF-FS 2021:32 on supplementary provisions to the EU regulations
- Official MPA guidance pages published in English and Swedish
Sweden operates inside the EU medical device system rather than running a parallel one. National requirements exist, but they apply to specific, identifiable areas such as registration, language, labeling and certain economic operator duties, rather than replacing the substance of MDR compliance.
Medical Device Registration Process in Sweden
The most important distinction to make before starting is that CE marking and Swedish market notification or registration are not the same regulatory action. CE marking demonstrates MDR conformity across the EU. Swedish registration is a separate national step that some economic operators must also complete before or when placing a device on the Swedish market.
Step 1: Determine the Device Classification
Confirm the MDR class under Annex VIII before anything else moves forward.
Step 2: Confirm Applicable EU MDR Requirements
Before anything else moves forward, confirm the product actually meets the MDR definition of a medical device. Then work out which articles and annexes apply.
Step 3: Complete the Conformity Assessment
Eligible Class I devices can self-declare. Everything else, Class IIa, IIb, and III, needs a Notified Body under whichever procedure applies: MDR Annex IX, X, or XI.
Step 4: Prepare Technical Documentation
Build the file required under MDR Annex II and Annex III, covering device description, design, risk management and verification data.
Step 5: Complete Clinical Evaluation
MDR Article 61 and Annex XIV govern this one. The clinical evidence built here needs to match the device’s risk class, not exceed it or fall short of it.
Step 6: Establish the Quality Management System
A QMS proportionate to device class is a requirement under MDR Article 10. Most manufacturers lean on ISO 13485 to show they’ve met it.
Step 7: Appoint an EU Authorized Representative
This step only applies to manufacturers based outside the EU. MDR Article 11 is where the requirement comes from.
Step 8: Complete Applicable Economic Operator and Device Registration/Notification
This is where Sweden Medical Device Notification Requirements come in. Depending on the operator’s role and where they’re already established, this can involve Eudamed economic operator and device registration (mandatory since 28 May 2026) and, for certain other operators and device categories, direct registration with the MPA under Swedish national legislation.
The MPA’s own guidance distinguishes registration obligations by role, including manufacturer, Authorized Representative, importer, and so on, and states that registration takes place once the device is ready to be placed on the EU market.
Not every device requires direct MPA registration; this should be confirmed against the MPA’s current registration guidance for the specific operator role involved.
Step 9: Ensure Labelling and IFU Compliance
Confirm Swedish-language requirements are met before the device ships.
Step 10: Place the Device on the Swedish Market
Manufacturer, importer, and distributor obligations under MDR Articles 10–16 all become active at this point.
Step 11: Maintain PMS and Vigilance Compliance
Post-market surveillance and vigilance reporting continue for as long as the device remains on the market.
Required Documents for Medical Device Registration in Sweden
The document set a manufacturer needs depends heavily on device class and economic operator role. It’s worth separating four categories:
Documents that demonstrate MDR conformity: the EU Declaration of Conformity, technical documentation under MDR Annex II, a clinical evaluation report per MDR Article 61, and the risk management file.
Documents demonstrating the Quality Management System: QMS procedures, ISO 13485 certification where it applies, supporting records referenced in the technical file, and post-market surveillance documentation.
Documents submitted or recorded for registration: Eudamed economic operator and device registration data, plus, where applicable to the specific operator role, information submitted to the MPA under national registration requirements.
Documents retained and made available to authorities on request: technical files, post-market surveillance records, the Authorized Representative’s written mandate and declarations of conformity, as per MDR Articles 10 -16 and Article 19.
Not every document listed here is submitted directly to the MPA. Which ones are depends on the operator’s specific role and the device category and this should be verified against current MPA guidance rather than assumed.
QMS Requirements for Medical Devices in Sweden
Sweden does not maintain a separate national Quality Management System (QMS) standard for MDR-regulated devices. Sweden MDR Compliance on the QMS side runs entirely through MDR Article 10, which requires manufacturers to operate a quality management system proportionate to device risk, covering design controls, supplier management, risk management, post-market surveillance, and corrective and preventive action processes.
ISO 13485 is the standard most manufacturers use to demonstrate this in practice, and Notified Bodies typically expect to see it referenced for Class IIa and above. That said, ISO 13485 certification itself isn’t automatically a separate legal requirement for every device class under MDR. For many Class I devices, a proportionate internal QMS can satisfy Article 10 without third-party certification.
Whether certification is expected for a given device should be checked against the applicable conformity route.
Medical Device Labelling Requirements in Sweden
Labelling and Instructions for Use for devices used in Sweden must give users access to information in Swedish, while information submitted to the authority itself can be in Swedish or English.
According to the MPA’s own published guidance on language requirements: “Every user of a medical device in Sweden shall have access to information written in Swedish on the labelling and in the instructions for use. Information provided to the Authority shall be either in Swedish or English.”
Beyond language, the substantive content of the label follows MDR Annex I general labelling requirements:
- CE marking and, where applicable, Notified Body identification number
- Manufacturer name and address, and Authorized Representative details where relevant
- Device identification and UDI information per MDR Article 27
- Batch or serial number, intended purpose, and required warnings
- Importer information where applicable, per MDR Article 13
Registration Timelines for Medical Devices in Sweden
There isn’t a single published Sweden Medical Device Registration Timeline that applies across all device classes and operator roles. Timing depends on several separate variables that move independently of each other:
| Stage | Key Drivers of the Timeline |
| CE marking / conformity assessment |
Device class, technical documentation readiness, clinical evidence
|
| Notified Body review |
Notified Body capacity and completeness of the submission. MDR does not set a fixed statutory review period
|
| Eudamed registration |
Completion of economic operator and device data entry
|
| Swedish MPA registration/notification |
Depends on operator role and whether the operator is already registered in another EU/EEA state
|
Manufacturers setting launch timelines should confirm the specific registration action directly with the MPA.
Medical Device Registration Costs in Sweden
The MPA’s operations are largely financed through fees, but that doesn’t mean every registration action carries a single, published price. Sweden Medical Device Registration Fees vary by the specific regulatory service involved.
Costs manufacturers typically budget for separately include:
- MPA administrative or registration fees, where applicable to the specific action
- Notified Body fees for conformity assessment
- Testing and clinical evaluation costs
- ISO 13485 certification and surveillance audit costs
- Swedish translation and labelling costs
- Regulatory consulting support
The applicable fee depends on the specific regulatory service and current fee schedule. Manufacturers should confirm current figures directly through the MPA.
Import Requirements for Medical Devices in Sweden
Sweden Medical Device Import Requirements combine MDR importer obligations with Swedish customs procedures.
Under MDR Articles 13 importers must verify:
- The device carries valid CE marking and a Declaration of Conformity exists
- The manufacturer has appointed an EU Authorized Representative where required
- UDI, labelling, and Instructions for Use meet MDR and Swedish language requirements
- Storage and transport conditions don’t compromise device conformity while in the importer’s control
- Traceability records are maintained, in line with MDR Articles 25-27
Regulatory conformity checks are distinct from general customs clearance. Customs procedures for goods entering Sweden are handled by Swedish Customs (Tullverket).
Post-Market Surveillance (PMS) Requirements in Sweden
PMS is a continuous manufacturer obligation under EU MDR. It doesn’t end once CE marking is complete or the device reaches the Swedish market.
Sweden Medical Device Post-Market Surveillance runs through the EU-wide vigilance system set out in MDR Articles 83-92 and Annex III, covering:
- A documented PMS system and PMS Plan
- PMS Reports for Class I devices, and Periodic Safety Update Reports (PSURs) for higher-risk classes
- Serious incident and Field Safety Corrective Action (FSCA) reporting
- Trend reporting and corrective action processes
Where a serious incident or FSCA involves the Swedish market, reporting obligations run to the relevant competent authority, in Sweden’s case the MPA, following the MDR vigilance chapter.
Conclusion
Sweden operates inside the EU MDR and IVDR system, but CE marking alone isn’t the finish line. Swedish registration, language, post-market surveillance, and vigilance obligations still apply, and each one carries its own documentation and timing to plan for.
If you need support with medical device registration, CE marking or Swedish market-entry strategy, reach out to the experts at info@artixio.com for guidance tailored to your product and market.
FAQs
Q1. Does Sweden require CE marking for medical devices?
Yes. CE marking under EU MDR is required to place a device on the Swedish market, as it is across the EU. CE marking alone, however, doesn’t cover Swedish national registration or labelling obligations.
Q2. Is medical device registration required in Sweden?
Certain economic operators and device categories must register with the MPA under Swedish national legislation, alongside Eudamed registration requirements at EU level. Whether direct MPA registration applies depends on the specific operator role, so this should be checked against the MPA’s registration guidance.
Q3. Do non-EU medical device manufacturers need an EC REP in Sweden?
Yes, under MDR Article 11, any non-EU manufacturer placing a device on the EU market, including Sweden, must appoint an EU Authorized Representative. This is an EU-wide requirement, not a Sweden-specific one.
Q4. Are Swedish-language labels and IFUs required?
Yes. Device users in Sweden must have access to labelling and IFU content in Swedish, per MPA guidance, even though information submitted to the authority itself can be in English.
Q5. How long does Medical Device Registration in Sweden take?
There’s no single published timeline covering all classes and registration steps. Timing depends on classification, Notified Body involvement and completeness of registration information, so this should be confirmed directly with the MPA and, where relevant, the Notified Body.
Q6. What are the Sweden Medical Device Post-Market Surveillance requirements?
Manufacturers must maintain an ongoing PMS system under MDR Articles 83-92 and Annex III, covering PMS Plans, PSURs where applicable, and vigilance reporting for serious incidents, with Swedish-market incidents reported to the MPA.
